SUBSCRIBE
SUBSCRIBE

Astellas Pharma US, Inc.

NEWS
220 Employees Chopped as Astellas Winds Down SoCal's Agensys
Deals
Astellas Takes Out Belgium Biotech in Deal Worth $853 Million
April 3, 2017
 · 
2 min read
Deals
Holding Onto Billions, Astellas CEO Hunts for Next Blockbuster
November 30, 2016
 · 
1 min read
Bay Area Startup Arcus Biosciences Lands $307 Million+ Deal With Taiho Pharma
Business
Little-Known Ganymed Grabs a $1.4 Billion Buyout Deal From Astellas
October 28, 2016
 · 
2 min read
220 Employees Chopped as Astellas Winds Down SoCal's Agensys
Policy
British Trade Group Suspends Astellas After Drugmaker Disguised the True Purpose of a Meeting Held for Doctors
June 24, 2016
 · 
2 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Policy
FDA Panel Backs Astellas Pharma Inc.'s CRESEMBA for Invasive Fungal Infections
January 22, 2015
 · 
2 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Business
SSF’s Cytokinetics, Inc. Snags $675 Million+ Deal With Astellas Pharma Inc.
December 23, 2014
 · 
2 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Business
Astellas Pharma Inc., Janssen Biotech Inc. To End Collaboration On RA Drug ASP015K
December 2, 2014
 · 
1 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Business
Ironwood Pharmaceuticals Earns $15 Million Milestone From Astellas Pharma Inc.
November 20, 2014
 · 
1 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Business
Astellas, Proteostasis Forge $1.2 Billion Genetic Disease Drug Pact
November 4, 2014
 · 
2 min read
Load More
AWARDS
  • 2022 Best Places to Work
  • 2023 Best Places to Work
JOBS
IN THE PRESS
Press Releases
IZERVAY® (avacincaptad pegol intravitreal solution) Demonstrated Increased Probability of Maintaining Driving Eligibility in Geographic Atrophy Patients
May 12, 2026
 · 
9 min read
Press Releases
Astellas to Highlight New Findings for Geographic Atrophy at ARVO 2026 Annual Meeting
April 30, 2026
 · 
9 min read
Press Releases
U.S. FDA Grants Priority Review to sBLA for PADCEV™ + Keytruda® as Perioperative Treatment for Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility
April 20, 2026
 · 
31 min read
Press Releases
Vir Biotechnology Announces Closing of Global Strategic Collaboration with Astellas for the Treatment of Prostate Cancer
April 17, 2026
 · 
6 min read
Press Releases
Dyno Therapeutics Announces Capsid License Exercised by Astellas for Skeletal Muscle-Targeted Gene Delivery, Validating AI-Powered Technology for Biological Sequence Design
April 8, 2026
 · 
3 min read
Press Releases
Astellas and Vir Biotechnology Announce Global Strategic Collaboration to Advance PSMA-targeting PRO-XTEN® Dual-masked T-Cell Engager VIR-5500 for the Treatment of Prostate Cancer
February 24, 2026
 · 
10 min read
Press Releases
VYLOY™ (zolbetuximab) Plus Chemotherapy Associated with Enhanced Survival Outcomes when Common Adverse Events are Effectively Managed, According to New Ad Hoc Analyses
January 9, 2026
 · 
15 min read
Press Releases
Autobahn Labs Forms Strategic Partnership with Astellas to Accelerate Academic Discoveries into New Medicines
December 11, 2025
 · 
2 min read
Press Releases
PADCEV™ Plus KEYTRUDA™, Given Before and After Surgery, Cuts the Risk of Recurrence, Progression or Death by 60% and the Risk of Death by 50% for Certain Patients with Bladder Cancer
October 19, 2025
 · 
27 min read
Press Releases
Nikon Instruments and Astellas announce a strategic collaboration to offer SakuLab-Cambridge MA resident companies access to advanced imaging capabilities provided by Nikon BioImaging Lab USA
June 17, 2025
 · 
2 min read
Load More